Efficiency of Acitretin in Combination With UV-B in the Treatment of Severe Psoriasis
The DOI matches its OpenAlex record.
Abstract
Compared with the antipsoriatic retinoid etretinate, the new aromatic retinoid acitretin represents an important advance due to its rapid elimination kinetics. Since in psoriasis vulgaris retinoids are used predominantly in combination regimens, we investigated the therapeutic efficacy of acitretin and UV-B compared with placebo and UV-B in a double-blind, randomized multicenter trial in 82 patients with severe psoriasis. They were treated with 35 mg of the study medication during the first 4 weeks of therapy and 25 mg thereafter, concomitantly with UV-B irradiation in increasing energy doses. Forty patients who underwent therapy with acitretin and UV-B and 38 patients who underwent therapy with placebo and UV-B were evaluated for efficacy. The target variables--psoriasis severity index and total UV-B dose--were reported at intervals of 2 weeks over a maximum period of 8 weeks. At the end of treatment, the psoriasis severity index decrease was 79% in the acitretin and UV-B group and 35% in the placebo and UV-B group. The response rate, defined as greater than or equal to a 75% decrease of the psoriasis severity index, was 60% for the combination treatment and only 24% for the control treatment. This treatment response was achieved with markedly lower cumulative UV-B energy. The median cumulative UV-B energy applied to reach 75% clinical improvement was 11.8 J/cm2 vs 6.9 J/cm2. Side effects showed a similar pattern in both groups. Our data show that the acitretin dramatically improves the results of UV-B treatment in patients with severe psoriasis. In addition, it markedly decreases the effective cumulative UV-B dose, thereby reducing the potential long-term hazards of UV irradiation. We conclude that the acitretin plus UV-B combination treatment represents a highly effective therapeutic regimen in severe psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Sbidian, E., Chaimani, A., Garcia-Doval, I., Do, G., Hua, C., Mazaud, C., Droitcourt, C., Hughes, C., Ingram, J. R., Naldi, L., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011535.pub2 · Cited by 433
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.08.026 · Cited by 413
Immunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
Current Use and Future Potential Role of Retinoids in Dermatology
Orfanos, C. E., Zouboulis, C. C., Almond-Roesler, B., & Geilen, C. C. (1997) · Drugs · doi:10.2165/00003495-199753030-00003 · Cited by 330
Walters, I. B., Burack, L. H., Coven, T. R., Gilleaudeau, P., & Krueger, J. G. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70076-9 · Cited by 211
Combination therapy to treat moderate to severe psoriasis
Lebwohl, M., Menter, A., Koo, J., & Feldman, S. R. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2002.12.002 · Cited by 182
A review of phototherapy protocols for psoriasis treatment
Lapolla, W., Yentzer, B. A., Bagel, J., Halvorson, C. R., & Feldman, S. R. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.12.054 · Cited by 167
Retinoid therapy for psoriasis
Yamauchi, P. S., Rizk, D., & Lowe, N. J. (2004) · Dermatologic Clinics · doi:10.1016/s0733-8635(03)00126-8 · Cited by 43
“Another study demonstrated that when patients with psoriasis were initially treated with 35 mg per day of acitretin during the first 4 weeks of therapy followed by concomitant therapy with UVB radiation plus 25 mg per day of acitretin and compared with the placebo group, there was a 79% decrease in the psoriasis sever…”
Background
Metadata
- Authors
- Ruzicka, T.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association
- Published
- 1990-04-01
- Volume
- 126
- Issue
- 4
- Pages
- 482-482
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2156734432
- Cited by
- 134
- References
- 0
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.